StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.38−0.01 (-0.72%)

Close on Nov 20, 2026Market cap $30.41MP/E –Yield –

Nexalin Technology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nexalin Technology's revenue for the twelve months ending Jun 30, 2026 was $217.16K, up 24.2% year over year. For fiscal 2025 it was $301.65K, up 78.8% from the year before. The highest annual figure on record is $1.32M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$301.65K+78.8%
FY2024Dec 31, 2024$168.72K+52.3%
FY2023Dec 31, 2023$110.75K-91.6%
FY2022Dec 31, 2022$1.32M+817.2%
FY2021Dec 31, 2021$144.07K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.16K-82.8%
Q1 FY2026Mar 31, 2026$14.95K-63.5%
Q4 FY2025Dec 31, 2025$171.90K+532.5%
Q3 FY2025Sep 30, 2025$18.15K-49.6%
Q2 FY2025Jun 30, 2025$70.59K+163.0%
Q1 FY2025Mar 31, 2025$41.02K-47.9%
Q4 FY2024Dec 31, 2024$27.18K-23.5%
Q3 FY2024Sep 30, 2024$36.03K+17.9%
Q2 FY2024Jun 30, 2024$26.84K-30.1%
Q1 FY2024Mar 31, 2024$78.67K-85.6%
Q2 FY2023Jun 30, 2023$35.54K-91.4%
Q1 FY2023Mar 31, 2023$30.56K-90.5%
Q4 FY2022Dec 31, 2022$38.42K+60.1%
Q3 FY2022Sep 30, 2022$545.32K+874.3%
Q2 FY2022Jun 30, 2022$414.29K–
Q1 FY2022Mar 31, 2022$323.32K–
Q4 FY2021Dec 31, 2021$24.00K–
Q3 FY2021Sep 30, 2021$55.97K–

More Nexalin Technology figures

See a number that looks wrong?